9R8F | pdb_00009r8f

CTX-M-14 complexes with 3D Boron Heterocycles synthetized via EnT Catalysis


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.40 Å
  • R-Value Free: 
    0.214 (Depositor), 0.221 (DCC) 
  • R-Value Work: 
    0.193 (Depositor), 0.202 (DCC) 
  • R-Value Observed: 
    0.193 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 9R8F

Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history

Literature

Fused 3D boron heterocycles via EnT catalysis: synthesis, modification and validation as beta-lactamase inhibitors.

Kortman, H.M.Fang, H.Bastick, K.A.C.Volkel, C.Oberthur, D.Seeberger, P.H.Perbandt, M.Molloy, J.J.

(2026) Chem Sci 17: 247-254

  • DOI: https://doi.org/10.1039/d5sc05518k
  • Primary Citation Related Structures: 
    9R8F

  • PubMed Abstract: 

    The installation of a boron unit into bioactive scaffolds continues to unlock novel modes of molecular recognition in drug discovery. As such, de novo strategies to access 3D boron-containing frameworks, that modulate the intrinsic reactivity at boron, are being intensively pursued. Herein, we report a visible light-mediated energy transfer (EnT) catalysis strategy that enables the [2 + 2] cycloaddition of boron-containing heterocycles to construct 3D frameworks with high structural complexity. Leveraging both inter- and intramolecular cycloadditions, a suite of angularly fused boron heterocycles was accessed, offering enhanced steric shielding and modular handles for additional interactions. A boron deletion strategy permits the synthesis of benzofuran scaffolds, otherwise inaccessible via direct EnT. Crucially, the resulting 3D architectures mimic structural motifs found in the potent β-lactamase inhibitor Xeruborbactam. The biological relevance of these frameworks was validated by NMR titration, p K a analysis, and co-crystallisation with serine β-lactamase CTX-M-14, revealing enantiospecific binding and a well-defined hydrogen bonding network. These results establish a versatile platform for the synthesis of functionalised boron heterocycles with direct translational potential in medicinal chemistry.


  • Organizational Affiliation
    • Department of Biomolecular Systems, Max-Planck-Institute of Colloids and Interfaces Am Mühlenberg 1 14476 Potsdam Germany john.molloy@mpikg.mpg.de.

Macromolecule Content 

  • Total Structure Weight: 28.11 kDa 
  • Atom Count: 2,239 
  • Modeled Residue Count: 262 
  • Deposited Residue Count: 262 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Beta-lactamase262Klebsiella pneumoniaeMutation(s): 0 
Gene Names: ctx-m-14
EC: 3.5.2.6
UniProt
Find proteins for D2D9A0 (Klebsiella pneumoniae)
Explore D2D9A0 
Go to UniProtKB:  D2D9A0
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupD2D9A0
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1JDI
(Subject of Investigation/LOI)

Query on A1JDI



Download:Ideal Coordinates CCD File
B [auth A](1~{R},2~{a}~{R},8~{b}~{R})-8-fluoranyl-3-oxidanyl-1,2,2~{a},8~{b}-tetrahydrocyclobuta[c][1,2]benzoxaborinine-1-carbonitrile
C11 H9 B F N O2
HJELYBQKKZFUDV-PJKMHFRUSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.40 Å
  • R-Value Free:  0.214 (Depositor), 0.221 (DCC) 
  • R-Value Work:  0.193 (Depositor), 0.202 (DCC) 
  • R-Value Observed: 0.193 (Depositor) 
Space Group: P 32 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 41.54α = 90
b = 41.54β = 90
c = 231.3γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata scaling
XDSdata reduction
PHASERphasing
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2026-03-25
    Type: Initial release